DA-3030

· Dong-A Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DA-3030, covering 2013-08-13 to 2013-08-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety of DA-3030 and to Explore the Efficacy for Diabetic Neuropathic Pain [Phase 1]